Prostatic Neoplasms Clinical Trials in San Antonio, Texas

4 studies are recruiting for prostatic neoplasms in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

    The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    The Urology Place, San Antonio, Texas
    Locations
    34 in total
    Run by
    Clarity Pharmaceuticals Ltd
  2. Prostate Active Surveillance Study

    The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This …

    Stage
    Not phased
    Ages
    21 and older
    Site
    University of Texas Health Science Center, San Antonio, San Antonio, Texas
    Locations
    11 in total
    Run by
    University of Washington
  3. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

    The purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of Part 2C of this study is to determine how safe the RP2R(s) of the combination of JNJ-87189401 and JNJ-78278343 is, with or …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    South Texas Accelerated Research Therapeutics, LLC (START), San Antonio, Texas
    Locations
    19 in total
    Run by
    Janssen Research & Development, LLC
  4. A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

    The goal of this clinical trial is to find out if FX-111 is safe enough to permit further studies in adult male participants with metastatic castration-resistant prostate cancer (mCRPC). It will also study the drug's pharmacokinetics (how the body breaks down FX-111) and how well FX-111 treats mCRP…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NEXT Oncology, San Antonio, Texas
    Locations
    10 in total
    Run by
    Flare Therapeutics Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.